Published
October 5, 2026
Patients who had Natera’s Panorama prenatal test or Horizon carrier screening between July 10, 2019 and September 2, 2026 and were billed more than $249 or $349 may qualify to claim a cash payment from the Natera $9.5 million genetic screening billing class action settlement. Claims close May 3, 2027.
Current Status
Claims are open. The deadline is May 3, 2027, for an online claim or for a paper claim form that the administrator receives by that date; the notice does not give a time of day or a timezone. The court granted preliminary approval on September 2, 2026, and the final approval hearing is set for March 2, 2027 at 9:00 a.m. Pacific. No payment date has been announced, and payments are made only after final approval and the end of any appeals.Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Status
Claims Open
Preliminary approval September 2, 2026 · final approval hearing March 2, 2027
Claim Deadline
May 3, 2027
Online, or a paper form received by that date
Estimated Payout
Up to $50, or a pro rata share
Pro rata share of 94.7% of the net fund if Natera’s records show payment over the threshold · otherwise up to $50
Proof Required
Yes — ID to file online
Class Member ID from the email or postcard notice · no receipts needed to file
What Changed Recently?
Natera, Inc. has agreed to pay $9.5 million to settle Calcaterra v. Natera, Inc., a class action in the U.S. District Court for the Northern District of California. The lawsuit claims that patients were not clearly told about the out-of-pocket costs they could face for Natera’s Panorama noninvasive prenatal test (NIPT) and Horizon genetic carrier screening. Judge Yvonne Gonzalez Rogers granted preliminary approval on September 2, 2026, which opened the claim process. The administrator, Kroll Settlement Administration, began sending email and postcard notices on or after October 2, 2026.Natera denies wrongdoing. It says patients had access to clear information about the potential costs, that it is in-network with most U.S. health plans, and that the overwhelming majority of patients owe less than $249 or $349, depending on the test and their health plan. Natera says it settled only to avoid the cost and disruption of continued litigation. The court has not decided who is right.
The dispute began in 2021 as a federal case, Copley v. Natera. It was dismissed in 2023 so that it could be refiled in California state court, gained a second plaintiff, and was moved back to federal court by Natera that December, where it became the Calcaterra case. A companion case remains on hold in San Mateo County Superior Court and will be dismissed if this settlement becomes final. The parties reached the agreement after mediation before David Geronemus of JAMS, and signed it on February 26, 2026.
This is a separate case from the earlier $8.25 million Natera prenatal testing settlement, whose claim deadline passed on July 24, 2026.
Who Qualifies?
The class is everyone in the United States who had Panorama noninvasive prenatal testing or Horizon genetic carrier screening performed by Natera between July 10, 2019 and September 2, 2026, and was billed more than the threshold for that test:- $249 for Panorama without microdeletions
- $349 for Panorama with microdeletions
- $349 for Horizon carrier screening
The class excludes people whose test was paid for entirely by insurance or another third party and who were not billed by Natera, and people tested as part of a clinical trial or research study. Also excluded are Natera and its affiliates, officers, directors and employees, Natera’s counsel of record, the presiding judge and family members, and anyone who opts out.
The court-approved notice says that anyone who received an email or postcard notice was listed as a potential class member.
How Much Can You Get?
Payments come from the net settlement fund: the $9.5 million minus notice and administration costs, attorneys’ fees and expenses, a service award to the named plaintiff, and taxes on the fund. The net fund is split between two groups according to Natera’s own billing records, and the first letter of each class member’s ID shows which group Natera’s records place them in.- Proof-of-payment group (ID starts with “A”): claimants whose payment above the threshold appears in Natera’s records share 94.7% of the net fund pro rata, in proportion to how much they paid over the threshold for each test.
- No-proof group (ID starts with “B”): claimants whose records show no such payment share 5.3% of the net fund, with each payment capped at $50. If that 5.3% is not used up, the rest moves to the proof-of-payment group.
No per-person estimate has been published. Individual amounts depend on how many people file and, in the proof-of-payment group, how much each claimant overpaid. The notice says Class Counsel will ask for attorneys’ fees of no more than 25% of the fund plus expenses (about $74,590 so far), and a service award of up to $7,500 for the named plaintiff. The court decides both amounts.
Three limits apply. A payment under $10 is made only to claimants who choose an electronic payment option; otherwise it is not paid. A person who also recovers from the earlier In re Natera Prenatal Testing Litigation settlement may have the combined total capped at what they actually paid out of pocket for the test. Money from uncashed or undeliverable payments may be redistributed to claimants. If a second distribution is not cost-effective, it goes to one or more nonprofits approved by the court (cy pres). None of it returns to Natera.
Natera has also agreed to add a line to the front of its patient invoices directing patients to the billing policy and payment options on the back. It will also add language to its test requisition forms explaining what patients must provide to use its price transparency program. Natera will make both changes within 60 days after the settlement becomes final.
What Proof or Notice ID Is Required?
The online claim form opens with a login screen that asks for the Class Member ID printed at the top of the email or postcard notice. That makes this a proof-required settlement even though no receipts are needed to file. Claimants who lost their notice can request help through the contact page on the official settlement website.The claim form asks which tests the claimant had, whether Natera billed more than the threshold, and whether they paid more than the threshold out of pocket. Listing the amounts paid is optional but, according to the form, speeds up verification. Claimants also sign a certification under penalty of perjury.
Claimants in the “B” group who say they paid more than the threshold but do not appear in Natera’s records as having paid will be contacted by email within 30 days after the claim deadline. They then have 30 days to submit documentation to move into the proof-of-payment group.
What Is the Deadline?
- Claim deadline: May 3, 2027, submitted online or mailed so that it is received by that date.
- Opt-out deadline: December 28, 2026, received by the administrator.
- Objection deadline: December 28, 2026, filed with or postmarked to the court.
- Final approval hearing: March 2, 2027 at 9:00 a.m. Pacific, before Judge Gonzalez Rogers in Oakland.
Class Counsel’s motion for fees, expenses and the service award is due by November 23, 2026 and will be posted on the settlement website. Class members who do nothing receive no payment and give up the claims released by the settlement. Claims for personal injury are not released.
How Do You Take Action?
Claims are filed on the official Natera genetic screening test settlement website. The online form moves through five steps after login: general instructions, contact information, information about the genetic screening test, payment selection, and certification and signature. Electronic payment options are available only on the online form. A paper claim form can be downloaded from the same site and mailed. The site also has the opt-out form and the court documents.What Happens Next?
The next step in court is the fee motion due November 23, 2026, followed by the December 28, 2026 opt-out and objection deadline and the March 2, 2027 final approval hearing. If the court grants final approval and no appeal is filed, the fees and service award are paid within five business days of the settlement’s effective date. Claimant payments follow after the claim deadline and the B-group documentation window. No payment date has been announced, and the hearing date can change, so updates will be posted on the settlement website.Sources and Verification
This page is based on the court-approved long-form notice, the class action settlement agreement and its exhibits, and the official settlement website. The notice is embedded below.- Notice of Proposed Class Action Settlement, Calcaterra v. Natera, Inc., No. 4:23-cv-06342-YGR (N.D. Cal.) — embedded below
- Class Action Settlement Agreement dated February 26, 2026, including the plan of allocation in Section 2.5 and the claim procedures in Section 4 (filed March 5, 2026 as Document 59-5)
- Court docket, No. 4:23-cv-06342 (N.D. Cal.), on CourtListener
- Official Natera genetic screening test settlement website — claim form, important dates and court documents
Questions
What does the letter at the start of the Class Member ID mean?
According to the court-approved notice, an ID beginning with A means Natera’s records show the class member paid more than the price threshold for their test, which puts them in the group that shares 94.7% of the net fund in proportion to the excess paid. An ID beginning with B means Natera’s records show no such payment, which puts them in the group capped at $50.
Can a B-group claimant who did pay more than $249 or $349 get a larger share?
Yes, if they can document it. The settlement agreement says that within 30 days after the May 3, 2027 claim deadline, the administrator will email claimants who said on the claim form that they paid more than the threshold but whom Natera’s records do not show as having paid. Those claimants then have 30 days to send documentation showing they belong in the proof-of-payment group.
Does a claim in the earlier $8.25 million Natera settlement rule someone out of this one?
No. The settlement agreement says membership in the class of In re Natera Prenatal Testing Litigation, No. 4:22-cv-00985-JST, does not prevent anyone from joining this class or filing a claim here, and this settlement does not release the claims in that case. Natera’s counsel and the administrator may make sure that a person’s combined recovery from both settlements does not exceed what that person paid out of pocket for the test.
What happens to a payment under $10?
It is paid only to claimants who chose an electronic payment method on the online claim form. A claimant whose payment works out to less than $10 and who did not choose electronic payment by the May 3, 2027 deadline receives nothing; that money goes back into the pool for a possible second distribution.
Who is not covered by the Natera settlement?
People whose test was paid entirely by insurance or another third party and who were never billed by Natera, people tested as part of a clinical trial or research study, people whose bill did not exceed the price threshold for their test, Natera and its officers, directors and employees, the presiding judge and family, and anyone who opts out by December 28, 2026.
Official Settlement Notice
For more class actions keep scrolling below.
Settlement Amount
$9,500,000
Case Title
Calcaterra v. Natera, Inc.
Case Number
4:23-cv-06342-YGR
Court
U.S. District Court, Northern District of California
Final Approval Hearing
March 2, 2027 at 9:00 a.m. PT
Judge Yvonne Gonzalez Rogers, Oakland · date may change
Administrator
Kroll Settlement Administration
Official Website
Genetic Screening Test Settlement
